Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kalinich

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Acta Psychiatrica Scandinavica|October 7, 2025
The Catatonia Quick Screen (CQS): A Rapid Screening Tool for Catatonia in Adult and Pediatric PopulationsJames Luccarelli, Mark Kalinich, Jo Ellen Wilson, et al.
Journal of the American Academy of Dermatology|April 5, 2021
Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysisShannon Wongvibulsin, Vartan Pahalyants, Mark Kalinich, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United StatesLilah Lopez, Thao Nguyen, Graham Weber, et al.
Plos One|June 10, 2021
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United StatesLilah Lopez, Thao Nguyen, Graham Weber, et al.
Journal for Immunotherapy of Cancer|April 1, 2021
Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USAMark Kalinich, William Murphy, Shannon Wongvibulsin, et al.
Cancer Discovery|August 15, 2018
A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast CancerTanya T Kwan, Aditya Bardia, Laura M Spring, et al.
Science (New York, N.Y.)|February 8, 2020
Deregulation of ribosomal protein expression and translation promotes breast cancer metastasisRichard Y Ebright, Sooncheol Lee, Ben S Wittner, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2018
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapyXin Hong, Ryan J Sullivan, Mark Kalinich, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaMark Kalinich, Irun Bhan, Tanya T Kwan, et al.
Cancer Discovery|January 6, 2018
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate CancerDavid T Miyamoto, Richard J Lee, Mark Kalinich, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Acta Psychiatrica Scandinavica|October 7, 2025
The Catatonia Quick Screen (CQS): A Rapid Screening Tool for Catatonia in Adult and Pediatric PopulationsJames Luccarelli, Mark Kalinich, Jo Ellen Wilson, et al.
Journal of the American Academy of Dermatology|April 5, 2021
Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysisShannon Wongvibulsin, Vartan Pahalyants, Mark Kalinich, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United StatesLilah Lopez, Thao Nguyen, Graham Weber, et al.
Plos One|June 10, 2021
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United StatesLilah Lopez, Thao Nguyen, Graham Weber, et al.
Journal for Immunotherapy of Cancer|April 1, 2021
Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USAMark Kalinich, William Murphy, Shannon Wongvibulsin, et al.
Cancer Discovery|August 15, 2018
A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast CancerTanya T Kwan, Aditya Bardia, Laura M Spring, et al.
Science (New York, N.Y.)|February 8, 2020
Deregulation of ribosomal protein expression and translation promotes breast cancer metastasisRichard Y Ebright, Sooncheol Lee, Ben S Wittner, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2018
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapyXin Hong, Ryan J Sullivan, Mark Kalinich, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaMark Kalinich, Irun Bhan, Tanya T Kwan, et al.
Cancer Discovery|January 6, 2018
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate CancerDavid T Miyamoto, Richard J Lee, Mark Kalinich, et al.
Pageof 2